donidalorsen
donidalorsen is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including DAWNZERA. Available dosage form: injection, solution.
Drug Details
- Generic Name
- donidalorsen
- Brand Names
- DAWNZERA
- Application Number
- NDA219407
- Sponsor
- Ionis Pharmaceuticals Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- DONIDALORSEN SODIUM
Indications and Usage
1 INDICATIONS AND USAGE DAWNZERA™ is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older. DAWNZERA is a prekallikrein directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older. ( 1 )